Results 41 to 50 of about 2,292 (152)

Typhoid fever in India: A growing concern requiring immediate preventive efforts

Health Science Reports, Volume 7, Issue 2, February 2024.
Kahan Mehta, Maruya Joshi, Mohamed A. Omar   +2 more
wiley   +1 more source

Efficacy trial of Vi polysaccharide vaccine against typhoid fever in south-western China

Bulletin of the World Health Organization, 2001
OBJECTIVE: To test the efficacy of locally produced Vi vaccine over a time period of longer than one year. METHODS: A double-blinded, randomized field trial was performed in Guangxi Zhuang Autonomous Region in south-western China, using 30 mg doses of ...
Yang H.H., Wu C.G., Xie G.Z., Gu Q.W., Wang B.R., Wang L.Y., Wang H.F., Ding Z.S., Yang Y., Tan W.S., Wang W.Y., Wang X.C., Qin M., Wang J.H., Tang H.A., Jiang X.M., Li Y.H., Wang M.L., Zhang S.L., Li G.L.   +19 more
doaj  

Blood Changes Following Injections of Typhoid-Paratyphoid Vaccine.

Experimental Biology and Medicine, 1927
In a study of the reactions produced in non-febrile patients by intravenous injections of typhoid-paratyphoid vaccine (given therapeutically for ocular inflammations1) we have verified certain findings reported by other workers, and made other observations not hitherto reported.
H. J. Howard, C. A. Mills
openaire   +1 more source

The Novartis Vaccines Institute for Global Health: a new initiative for developing vaccines for neglected diseases in developing countries

Journal of Infection in Developing Countries, 2008
In July last year, at the time the first issue of the Journal of Infection in Developing Countries was going to press, a group of infectious disease experts met in Siena, Italy, to consider the direction of another important new initiative in the fight ...
Allan Saul, Rino Rappuoli.
doaj  

Typhoid Vaccine Studies VII: Typhoid-Paratyphoid Vaccine

American Journal of Public Health and the Nations Health, 1943
D, Longfellow, G F, Luippold
openaire   +3 more sources

Development and validation of immunological assays for preclinical evaluation of a novel bivalent typhoid conjugate vaccine. [PDF]

Hum Vaccin Immunother
Gavade V, Kamat C, Avalaskar N, Haridasyam V, Sargar S, Chavan A, Jadhav V, Kadam S, Borude B, Sarma AD, Mallya A, Dhere RM.   +11 more
europepmc   +1 more source

RESPONSE OF NORMAL AND MULTIPLE SCLEROTIC SUBJECTS TO TYPHOID-PARATYPHOID VACCINE INJECTIONS [PDF]

Journal of Neurology, Neurosurgery & Psychiatry, 1961
E J, FIELD, C A, GREEN, H, MILLER
openaire   +2 more sources

Co-administration of oral killed whole-cell recombinant cholera toxin B-subunit vaccine (WC-rCTB) and live Salmonella Typhi Ty21a vaccine: a prospective randomized open-label trial. [PDF]

J Travel Med
Riekkinen M, Terrinoni M, Pakkanen SH, Kaim J, Vahlberg T, Lundgren A, Kantele A.   +6 more
europepmc   +1 more source

Preclinical evaluation of a bivalent conjugate vaccine against <i>Salmonella</i> Typhi and Paratyphi A. [PDF]

Front Immunol
Alfini R, Di Benedetto R, Carducci M, Paradkar V, Mallubhotla H, Renukuntla S, Patel D, Manoharan S, Panchakshari M, Kyasani M, Sengupta N, Martin LB, Rossi O, Rondini S, Giannelli C, Micoli F.   +15 more
europepmc   +1 more source

Advancing typhoid conjugate vaccine implementation in Asia: Regional policy priorities. [PDF]

Vaccine
Carter AS, Steele D, John J, Saha S, Laurens MB, Minta AA, Volavola L, Moedjito I, Phounphenghack K, Mahat D, Nyein SL, Gautam A, Sespeñe MFVS, Pati T, Huong NTT, Gupta N, George LS, Jayaprakasam M, Gupta A, Garrett DO.   +19 more
europepmc   +1 more source